Jennison Associates’s La Jolla Pharmaceutical Company LJPC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q1 | – | Sell |
-3,268,744
| Closed | -$30.8M | – | 719 |
|
|
2018
Q4 | $30.8M | Sell |
3,268,744
-10,528
| -0.3% | -$99.3K | 0.03% | 280 |
|
|
2018
Q3 | $66M | Buy |
3,279,272
+90,739
| +3% | +$1.83M | 0.06% | 210 |
|
|
2018
Q2 | $93M | Buy |
3,188,533
+51,471
| +2% | +$1.5M | 0.09% | 159 |
|
|
2018
Q1 | $93.4M | Buy |
3,137,062
+916,580
| +41% | +$27.3M | 0.09% | 161 |
|
|
2017
Q4 | $71.5M | Buy |
2,220,482
+167,635
| +8% | +$5.39M | 0.07% | 212 |
|
|
2017
Q3 | $71.4M | Sell |
2,052,847
-620
| -0% | -$21.6K | 0.07% | 213 |
|
|
2017
Q2 | $61.1M | Buy |
2,053,467
+285,254
| +16% | +$8.49M | 0.06% | 244 |
|
|
2017
Q1 | $52.8M | Buy |
1,768,213
+1,510,504
| +586% | +$45.1M | 0.06% | 252 |
|
|
2016
Q4 | $4.52M | Hold |
257,709
| – | – | 0.01% | 510 |
|
|
2016
Q3 | $6.13M | Buy |
257,709
+5,272
| +2% | +$125K | 0.01% | 496 |
|
|
2016
Q2 | $4.04M | Buy |
252,437
+3,863
| +2% | +$61.8K | ﹤0.01% | 494 |
|
|
2016
Q1 | $5.2M | Buy |
+248,574
| New | +$5.2M | 0.01% | 481 |
|